Meet some of our RPS Fellows

Meet some of our recently-appointed Fellows

Peter Mulholland

Peter Mulholland is currently a neonatal pharmacist at the Royal Hospital for Children in Glasgow. In addition he is the lead pharmacist for immunoglobulins for NHS Greater Glasgow and Clyde Health Board, and the lead pharmacist for Procurement Strategy for the board.

Peter qualified from the University of Strathclyde in 1981. His first senior role was as the Quality Control pharmacist at the Southern General Hospital in Glasgow, from here he took on the lead for pharmacy computer services. Peter attained membership of the College of Pharmacy Practice by examination in 1993. This was converted to a MSc in Clinical Pharmacy in 1997 at Liverpool John Moore’s University, and Fellowship of the College was awarded in 2007, following assessment against the Competency Development and Evaluation Group (CoDEG) standards. He was the second recipient of the College’s Bamford Silver Jubilee cup, in 2008. He acted as a tutor, and assessor, for the Scottish Hospital Pharmacy Vocational Training Scheme, which provides a clinical development programme for junior pharmacists.

Peter's main clinical role and research role has always been the care of neonates. He joined the Neonatal and Paediatric Pharmacists Group (NPPG) on its foundation in 1994 and has been involved with the group ever since, joining the committee in 1997. This resulted in taking on roles that would not necessarily be associated with a pharmacist working in Scotland, such as membership of the NPSA group, looking at care bundles for gentamicin use in neonates and, more recently, one of two pharmacists on the NICE Guideline development group for neonatal parenteral nutrition and the subsequent development of Quality Standards for the group.

What does being a Fellow mean to me? 

Throughout my career I have been fortunate to have bosses who have allowed and supported me to develop my varied roles. I am also passionate about developing junior pharmacists to reach their full potential. None of this is possible without the additional support of professional development organisations either at a specialist level such as NPPG, or at a national level like the RPS. I am honoured to have had my work recognised with Fellowship of the Royal Pharmaceutical Society.


Dr Amira Guirguis

Dr Amira Guirguis

Amira originally trained as an accountant, has pursued a career as a pharmacist and gained her PhD in the in-field detection of New Psychoactive Substance (NPS). She has worked in community and hospital pharmacy, and as an academic and researcher. 

After completing a BSc in Accountancy, Amira pursued her Pharmacy degree at the University of Hertfordshire. Amira worked in community and hospital pharmacy before pursuing her interests in academia and research. Amira had a passion for combining science and practice, so as she was completing her PhD on novel psychoactive substances and their detection, she was leading on national borough-level talks with service providers to raise awareness about these novel drugs, highlighting the role of the pharmacist in reducing harms from these drugs. Amira was very passionate about Foundation pharmacists (previously known as pre-registration pharmacists) and was engaged in their education and training with providers such as ProPharmace. She’s been also involved in the training of designated supervisor (previously known as tutors) training, and the ProPharmace/HEE Educational and Practice Supervisors training of pharmacy team members across sectors.

Amira is particularly known for the breadth of her knowledge and experience in drug detection particularly the novel psychoactive substances, where she has made major contributions through her PhD and to the trial of drug checking in community substance misuse services in collaboration with (Addaction). The project piloted the first home licensed service and had a great impact on drug policy in the UK.

Amira sits on CD national Boards to advise and share information on matters related to controlled drugs and substances with a potential for misuse and/ or diversion. This is owing to Amira’s expertise in current projects that she co-supervises with colleagues from Swansea University, the University of Hertfordshire and the University of Anglia Ruskin on pharmacovigilance and medicines diversion, drug abuse and mental health, opioid use disorders, smuggled drug detection in prisons, evaluation of healthcare professionals’ knowledge and response to people who use novel psychoactives, and analysis of drugs on the web to improve preparedness to future threats. 

Amira is known for promoting the role of the pharmacist in reducing drug related harm through national and international forums. Amira is committee member of the Joint Pharmaceutical Analysis Group (JPAG) and the Geoffrey Philips Award Chair, she is a member of the RPS Science and research Committee and a Board member of the RPS Medicines, Ethics and Practice. Amira was also on the Women to Watch List 2020.

Amira is now the Programme Director of the 4-Year MPharm and the 5-Year MPharm with a Foundation (Preparatory) Year at Swansea University. Amira contributed to the early development and establishing of these programmes, which welcomed their first cohorts in September 2021. 

What does being a Fellow mean to me?

It is an honour to have been designated a Fellow of the Royal Pharmaceutical Society. It is humbling to be recognised by my peers. I was incredibly fortunate to have worked with inspiring pharmacists and colleagues within the profession and from the wider healthcare team.

Dr Paul Goggin

Paul_groggin

Paul has been a practising pharmacist for nearly 30 years and is currently the Global Head of Switch (Science) at Sanofi.  Paul is known for pursuing his interest in the pharmacy profession initially “the hard way”. Paul started his career as an NHS ancillary worker in the Sterile Products Unit at Kent and Canterbury Hospital, went on to train as a pharmacy technician and combined a full-time job, with day release to study Pharmaceutical Sciences BTEC as well as ‘A’ level chemistry at night school to pave his way to studying for a Pharmacy degree. 

After completing his Pharmacy degree at Brighton, Paul pursued his interest in clinical pharmacy and passion for science with pre-registration training at Guys Hospital, and post-graduate research at University College London, leading to his Doctorate in 1996. Paul is particularly known for the breadth of his knowledge and experience in pharmaceutical formulation science, where he has made a major contribution to the development of many medicines by virtue of his strong formulation design knowledge and expertise, focusing around patient needs. These include - transdermal products (Elan) - soft gel and fast melts (R P Scherer and Pfizer) -  a novel, patented oropharyngeal delivery system (Pfizer) - Oral, dermal, and inhaled products (Vectura). Paul’s CV lists a significant number of patents which he had filed and/or held, which is a great recognition of the innovation employed in these varied formulation design projects.

In 2007, Paul re-joined Pfizer to lead a research group focused on product enhancement. Paul is known for combining a deep knowledge of drug formulation and delivery with focus on clinical outcomes. A key achievement during this phase of his career was the design and development of a novel “in house” orally disintegrating tablet platform for both Viagra® and Norvasc®.

Paul’s interest in the relationship between drug delivery and clinical outcomes is clearly shown through his numerous publications. These include peer-reviewed pharmaceutical science papers and presentations, in addition to many publications related to patient prescribing across a broad range of therapeutic areas. Paul is also known for his enthusiasm and commitment in developing others and specifically, supporting the training of pharmacists. Paul has held long-term teaching commitments to two of the London Pharmacy Schools at UCL and KCL. Paul has been a visiting lecturer at these two schools of pharmacy for more than 20 years, and he has provided this support while doing a full-time, demanding role in industry. 

It is testament to his enthusiasm and passion for education of pharmacists, that Paul has dedicated his personal time to support these establishments. He was also a key member of the Pfizer pre-registration team from 2007 – 2011. During this time, Paul helped build a successful partnership with several hospital and community pharmacies in order to offer industrial pre-registration placements. Paul was an inspiring tutor, promoting the role of the industrial pharmacist, always ensuring a close focus on patient needs. 

In 2011 Paul switched from product development to medical affairs and took a position as Senior Director with the newly created Pfizer Consumer Healthcare. Thanks to his knowledge of the science behind Viagra® and his familiarity with international pharmacy, he was asked to head up the medical team that would go on to switch Viagra® from Rx to OTC in several markets. This work involved Paul talking to over 1000 pharmacists around the world to understand what pharmacists needed in order to ensure that men got the right advice as to whether they should use the product. This 8-year programme involved consultation with many regulatory agencies (FDA, TGA, EMA, MHRA etc), medical organisations and pharmacy associations including the Royal Pharmaceutical Society. The latter were invaluable in the development of pharmacy facing education and training and the results of this work can be found at https://www.viagraconnect.co.uk/

During this time Paul also worked on various other innovative switch programmes in pain management, women’s health, sleep disorders and in GI health, where again he demonstrated his commitment to pharmacy by working with pharmacists all over the world on the successful Nexium® reclassification. He now heads the switch group at Sanofi. In summary, Paul is known for promoting the role of the pharmacist, for innovative product development, for supporting Rx to OTC switches, and for considering the patient perspective as a guiding principle of his work.

What does being a Fellow mean to me?

I have been lucky to work with many inspiring pharmacists and other scientific experts during my career and it is testament to these individuals. 

At Brighton this included the excellent teaching staff at the time, including Professors Marriott, Martin, Gard, Horne, Davies and the legendary Pam Graham. At Guys, I worked with the Andy Kostrzewski, Douglas Maclean and later with Aamer Safdar. At UCL School of Pharmacy, Professors Craig, Taylor, Bates and Gaisford and Drs Lloyd and Williams and of course Dave McCarthy. Thanks to all the “SOPSAP” cricketers making it a very enjoyable time. 

At KCL Professors Martini, Martin, Marriott Hylands and Brown. Special mention to Dr Graham, Jackson, Dr David Edwards, Professors Hackett Giuliano, and Kirby, to Dr Irwin Goldstein and Dr Terry Maguire. 

Thanks to all of those in our industry colleagues past and present, you know who you are!! Huge thanks to Professor John Staniforth, Drs Williams, Clarke, Bajwa and McGovern for their support and guidance.

Finally, to Paul Knowles who walked with me on the early journey, to my family, my children and above all Nicola, who made this all possible, I share this honour with you.

Babir Malik

Babir Malik

Babir Malik is currently the Weldricks Pre-reg Lead and Teacher Practitioner at the University of Bradford. He also practices as a relief pharmacist for Weldricks Pharmacy in Scunthorpe.

Babir began his pharmacy journey in 2003, at the University of Bradford, after completing a Biomedical Sciences degree previously at the same university. In 2007, upon graduating, he undertook his pre-registration training with Weldricks Pharmacy, whereby he then embarked on a Postgraduate Diploma in Community Pharmacy at Keele University in 2009. Babir has also completed his RPS Faculty journey and is at Stage 1.

One of his most enjoyable roles is being a Charity Ambassador for the Pharmacist Support. As part of this he jumped out of a plane in 2018 and helped raise over £1500. He is an RPS Mentor, Conference Panel member for the RPS Pre-registration conferences and on the MEP Advisory Board.

After many attempts for a role in academia, he successfully became Weldricks Teacher Practitioner, at the University of Bradford. As a Teacher Practitioner, his role includes being the Calculations Lead for the School of Pharmacy and Medical Sciences. Furthermore, Babir undertook a 10 week secondment as a Clinical Commissioning Group Pharmacist early in 2016. Babir also sits on the Chemist and Druggist Clinical Advisory Board.

Babir actively supports pre-registration pharmacists via his many social media groups and he works with a variety of organisations including the  RPS, Green Light Campus, PCPA and the British Islamic Medical Association to run sessions for pre-registration pharmacists. He is also the PCPA National Early Careers Lead and Ontrack Question Writer and Reviewer.

He has been a Pre-registration Tutor as well as sitting on the Rotherham Local Pharmaceutical Committee alongside being a Dementia Friend Champion, whereby he has generated over 300 dementia friends. He is also a UKCPA Community Pharmacy Group Committee Member.

In June 2016, his pharmacy in Scunthorpe was awarded the Chemist and Druggist Medicines Optimisation Award for their innovative LPS Intervention Service.

He is quite active on social media and enjoys interacting with the whole pharmacy community and has also written two popular light-hearted books about pharmacy in 2013 under the pseudonym “Mr Dispenser”. He wrote 100 questions for the ‘Pharmacy Registration Assessment Questions’ book which was released in April 2016 and recently released a ‘Pharmacy Law Quizzes’ short book. He has spoken at many conferences across the UK and has been invited to speak at overseas events in Ireland, France, Holland and Jersey.

What does being a Fellow mean to me?

I am honoured to be a Fellow after 12 years of practice. For me, being a pharmacist means helping others even after I finish work in the pharmacy or leave the lecture room. I have been incredibly fortunate to meet some amazing individuals who have inspired me and constantly push me to do more. They all have one thing in common: they are members of the RPS.

Jatinder Harchowal

Jatinder Harchowal

Jatinder Harchowal is currently Chief Pharmacist in the Royal Marsden Hospital (RMH) and is currently the Chair of the Royal Pharmaceutical Society’s Hospital Expert Advisory Group. Jatinder was previously Chief Pharmacist in Brighton & Sussex University Hospitals NHS Trust and Ealing Hospital.

I qualified in 1991 after completing the four-year integrated degree at the University of Bradford. My first job as a pharmacist was as a basic grade in the Queen Elizabeth Hospital, Birmingham, where I completed my postgraduate diploma in clinical pharmacy in 1993. I then moved to London as resident pharmacist in Lewisham Hospital before moving to Charing Cross Hospital to work in clinical services and clinical trials. In 1995, I moved to King’s College Hospital as their renal specialist pharmacist which was an area of huge interest to me and I was fortunate to be part of the UK Renal Pharmacy Group committee and helped edit the first edition of the Renal Drug Handbook.

I spent six years in King’s and eventually became the Associate Director of Pharmacy there before leaving in 2001 having obtained an MSc in Clinical Pharmacy Practice from London School of Pharmacy and a Diploma in Management Studies from Kingston University. After a year of travelling, I came back to the UK and worked as Clinical Services lead in Barts and the London before becoming Chief Pharmacist and Assistant Director of Operations in Ealing Hospital in 2004. After 5 years at Ealing, I was appointed as Chief of Pharmacy in Brighton & Sussex University Hospitals (BSUH) where I stayed from 2009-2014. Whilst at BSUH, I completed a Masters in Leadership and Quality Improvement (Generation Q). In 2014, I was appointed as Chief Pharmacist / Clinical Director for Clinical Support Services in the Royal Marsden NHS Foundation Trust. My interest in continuous improvement has allowed me to recently be seconded as Head of Quality Improvement in the Marsden and in 2020, I was privileged to be seconded as Director of Pharmacy for the Nightingale Hospital, London, helping set the hospital up and run the pharmacy service.

What does being a Fellow mean to me?

I have always tried to promote the profession in every job I have undertaken and believe in giving my teams the opportunity to showcase their skills as I feel proud in what we can achieve together. To have been made a Fellow of the RPS and have received this recognition by my peers is both humbling and a privilege. Thank you.

Dr Victoria Silkstone

Dr Victoria Silkstone qualified as a pharmacist from the University of Bradford in 1995 having undertaken pre-registration training at the Norfolk and Norwich Hospital and an independent community pharmacy in Bradford. She completed a PhD in inhalation drug delivery and has spent the next 20 years in pharmacy education inspiring and developing the next generation of pharmacists.

Victoria commenced a PhD immediately after qualification focused around inhalation drug delivery, alongside working as a community pharmacist. She has maintained an interest in in drug delivery and this has formed the basis of her collaborations with the pharmaceutical industry as part of her current role at the University of Manchester. 

Following completion of her PhD Victoria joined Bradford School of Pharmacy firstly as Boots Teacher Practitioner and then as Placements Tutor for the 5-year MPharm and was later promoted to Programme Leader for the 5-year intercalated MPharm.

In 2013, she joined the University of Manchester, where she introduced an innovative programme of community pharmacy, general practice and industrial placements within the MPharm programme. Victoria was also pivotal to the development of North West Centre for Advanced Drug Delivery (NoWCADD), a partnership between The University of Manchester and AstraZeneca. As part of this, she designed an innovative educational strategy which aims to equip and inspire undergraduate students to become pharmaceutical scientists of the future. This is achieved through collaborating closely with AZ staff on input into the curriculum, unique placements as well as joint undergraduate research projects. This unique industrial partnership within the Manchester curriculum is becoming one of the most attractive aspects for MPharm applicants, particularly for those with a longer term interest in industry careers. 

What does being a Fellow mean to me? 

I am passionate about being both a pharmacist but also inspiring the next generation of pharmacists that will work across sectors with the overall aim of improving patient care. I am delighted to be recognised as a fellow and truly believe that as a profession we need the Royal Pharmaceutical Society to provide leadership for the wider profession.